Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers

PHASE1CompletedINTERVENTIONAL
Enrollment

313

Participants

Timeline

Start Date

September 8, 2015

Primary Completion Date

November 18, 2019

Study Completion Date

November 18, 2019

Conditions
Advanced Solid TumorsHead and Neck CancerPancreatic CancerOvarian CancerRenal Cell CarcinomaMalignant GliomaNon-small Cell Lung Cancer
Interventions
BIOLOGICAL

Cabiralizumab

Solution for IV administration

BIOLOGICAL

Nivolumab

Solution for IV administration

Trial Locations (39)

10065

Memorial Sloan Kettering, New York

14263

Roswell Park Cancer Institute, Buffalo

15232

University of Pittsburgh Cancer Institute, William M. Cooper Ambulatory Pavilion of the Hillman Cancer Center, Pittsburgh

19104

Hospital of the University of Pennsylvania, Philadelphia

19107

Thomas Jefferson University Hospital, Philadelphia

21287

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore

29425

Hollings Cancer Center, Medical University of South Carolina, Charleston

30322

Emory University Hospital, Atlanta

33140

Mount Sinai Comprehensive Cancer Center, Miami Beach

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

37232

Henry-Joyce Cancer Clinic, Vanderbilt-Ingram Cancer Center,, Nashville

40202

Norton Cancer Institute, Norton Healthcare Pavilion, Louisville

45219

The Christ Hospital, Cincinnati

46202

Indiana University Health Hospital, Indianapolis

48201

Karmanos Cancer Institute, Detroit

48202

Henry Ford Hospital, Detroit

52242

University of Iowa Hospitals and Clinics, Iowa City

55407

Allina Health, Virginia Piper Cancer Institute, Minneapolis

60612

Rush University Medical Center, Chicago

60637

University of Chicago Medical Center, Chicago

75246

Baylor Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas

75390

University of Texas Southwestern Medical Center, Dallas

77030

Mischer Neuroscience Associates, The University of Texas Health Science Center at Houston, Houston

The University of Texas MD Anderson Cancer Center, Houston

78229

Cancer Therapy & Research Center, University of Texas Health Science Center at San Antonio, San Antonio

South Texas Accelerated Research Therapeutics, LLC, San Antonio

84112

Huntsman Cancer Institute, Salt Lake City

85258

Scottsdale Healthcare Hospitals DBA Honor Health, Scottsdale

90033

Norris Comprehensive Cancer Center, University of Southern California, Los Angeles

90048

Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Center, Los Angeles

90403

Sarcoma Oncology Research Center, Santa Monica

90404

UCLA Hematology/Oncology- Santa Monica, Santa Monica

92093

Moores UC San Diego Cancer Center, La Jolla

94143

University of California, San Francisco, San Francisco

95817

UC Davis Comprehensive Cancer Center, Sacramento

97213

Providence Portland Medical Center, Portland

97239

Oregon Health and Science University, Portland

98109

Seattle Cancer Care Alliance, Seattle

02215

Dana Farber Cancer Institute, Boston

Sponsors
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Five Prime Therapeutics, Inc.

INDUSTRY